Avitas Wealth Management LLC Vertex Pharmaceuticals Inc Transaction History

Avitas Wealth Management LLC

$651 Million
Q1 2024

A detailed history of Avitas Wealth Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Avitas Wealth Management LLC holds 1,343 shares of VRTX stock, worth $647,178. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,343

Previous 1,354 0.81%

Holding current value

$647,178

Previous $550,000 2.0%

% of portfolio

0.09%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$407.69 - $446.08 $4,484 - $4,906	-11 Reduced 0.81%	1,343 $561,000
Q4 2023 Jan 24, 2024	SELL	$343.0 - $410.68 $3,773 - $4,517	-11 Reduced 0.81%	1,354 $550,000
Q3 2023 Nov 02, 2023	SELL	$338.18 - $362.46 $13,865 - $14,860	-41 Reduced 2.92%	1,365 $474,000
Q2 2023 Jul 18, 2023	SELL	$314.42 - $351.91 $5,659 - $6,334	-18 Reduced 1.26%	1,406 $494,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $12,745 - $14,539	-45 Reduced 3.06%	1,424 $448,000

Q4 2022 Jan 10, 2023	BUY	$285.76 - $321.48 $571 - $642	2 Added 0.14%	1,469 $0
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $3,559 - $3,971	13 Added 0.89%	1,467 $425,000
Q2 2022 Jul 29, 2022	BUY	$234.96 - $292.55 $341,631 - $425,367	1,454 New	1,454 $410,000
Q3 2021 Oct 28, 2021	SELL	$181.39 - $202.99 $970,980 - $1.09 Million	-5,353 Closed	0 $0
Q2 2021 Jul 12, 2021	BUY	$187.49 - $221.1 $32,998 - $38,913	176 Added 3.4%	5,353 $1.08 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $20,909 - $24,372	101 Added 1.99%	5,177 $1.11 Million
Q4 2020 Feb 26, 2021	BUY	$207.01 - $276.09 $204,939 - $273,329	990 Added 24.23%	5,076 $1.2 Million
Q3 2020 Oct 06, 2020	BUY	$255.65 - $303.1 $52,919 - $62,741	207 Added 5.34%	4,086 $1.11 Million
Q2 2020 Jul 30, 2020	SELL	$225.48 - $295.8 $126,268 - $165,648	-560 Reduced 12.62%	3,879 $1.13 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $251,710 - $312,240	-1,260 Reduced 22.11%	4,439 $1.06 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $2,834 - $3,806	-17 Reduced 0.3%	5,699 $1.25 Million
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $418,234 - $470,718	2,516 Added 78.63%	5,716 $968,000
Q2 2019 Jul 23, 2019	SELL	$164.61 - $190.37 $13,333 - $15,419	-81 Reduced 2.47%	3,200 $587,000
Q1 2019 May 01, 2019	SELL	$163.73 - $194.7 $32,909 - $39,134	-201 Reduced 5.77%	3,281 $604,000
Q4 2018 Feb 08, 2019	SELL	$151.91 - $192.21 $2,126 - $2,690	-14 Reduced 0.4%	3,482 $577,000
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $47,132 - $54,159	281 Added 8.74%	3,496 $674,000
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $468,489 - $546,421	3,215 New	3,215 $546,000

Others Institutions Holding VRTX

# of Institutions

1,625

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.

Account

Avitas Wealth Management LLC Vertex Pharmaceuticals Inc Transaction History